课题基金 / 基金详情

TESTING HBV-KOREA SINGLE VIAL FORMULATION FOR IMMUNOGENICITY RESPONSE IN BABOONS

TESTING HBV-KOREA SINGLE VIAL FORMULATION FOR IMMUNOGENICITY RESPONSE IN BABOONS
测试 HBV-Korea 单瓶制剂在狒狒中的免疫原性反应
批准号:
7349776
负责人:
KATHLEEN M BRASKY
金额:
$0.04万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2007-04-30

项目摘要

项目成果

KATHLEEN M BRASKY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a three-part study. The main objective of part one is to collect two lymph nodes and one skin biopsy from 6 baboons, and culture lymph node cells in vitro (for 6 hours) to test for background levels of gene products, using PCR analysis. The purpose of part two of this study is to determine if there is a correlate between the immune activity measured in vitro (Part 1) with in vivo activity in baboons following subcutaneous injection with 1018 ISS, 1018 ISS-PMXB, C274 and C792 formulations. For this part of the study 10 baboons will be added. The purpose of part three is to test the in vitro and in vivo responses of baboons to oligonucleotides. This experiment will determine if in vitro assays are possible for the detection of gene products of cellular activation after culture of cells with oligonucleotides/PMXB. The testing of these products has the potential to aid in the development of a treatment for asthma in humans. This study is currently in progress.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR ONTOGENY OF ORAL MUCOSAL RESISTANCE TO SIV
EXPERIMENTAL INFECTION OF COMMON MARMOSET WITH EASTERN EQUINE ENCEPHALITIS VIRUS
BABOON OPSONOKINE VACCINE STUDY
TRX1 LEUCINE AND TRX1 PROLINE MABS GIVEN IV: PK, SAFETY, AND TOX
国内基金
海外基金
糖基化RNA-lncRNA-GLY1通过激活ITGB1通路促进HBV相关肝癌转移的机制
  • 批准号:
    2026JJ81914
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周克兵
  • 依托单位:
基于人工智能算法构建HIV/HBV合并感染预后模型
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    徐锋
  • 依托单位:
HBV编码蛋白HBx通过调控ZRANB2-TRAF4轴信号通路维持肝细胞癌干性并促进肝癌发生发展
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    潘甬厦
  • 依托单位: